Citadel Advisors’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.04M Buy
363,333
+306,381
+538% +$4.88M ﹤0.01% 4321
2025
Q4
$925K Buy
56,952
+28,868
+103% +$471K ﹤0.01% 7575
2025
Q3
$420K Sell
28,084
-772,605
-96% -$9.41M ﹤0.01% 9546
2025
Q2
$9.33M Buy
800,689
+656,351
+455% +$5.96M 0.01% 3126
2025
Q1
$1.07M Sell
144,338
-82,644
-36% -$635K ﹤0.01% 6809
2024
Q4
$1.36M Buy
226,982
+17,556
+8% +$96.8K ﹤0.01% 6418
2024
Q3
$1.07M Sell
209,426
-192,696
-48% -$840K ﹤0.01% 6744
2024
Q2
$1.46M Buy
402,122
+320,224
+391% +$1.02M ﹤0.01% 5886
2024
Q1
$263K Buy
81,898
+79,027
+2,753% +$306K ﹤0.01% 9757
2023
Q4
$14.1K Sell
2,871
-141,121
-98% -$644K ﹤0.01% 12897
2023
Q3
$785K Sell
143,992
-570,530
-80% -$3.77M ﹤0.01% 7078
2023
Q2
$4.79M Sell
714,522
-87,981
-11% -$654K 0.01% 3716
2023
Q1
$7.09M Buy
802,503
+259,225
+48% +$2.29M 0.01% 3269
2022
Q4
$4.15M Sell
543,278
-292,537
-35% -$2.28M ﹤0.01% 4179
2022
Q3
$5.95M Buy
835,815
+434,246
+108% +$4.09M 0.01% 3578
2022
Q2
$3.25M Buy
401,569
+199,698
+99% +$1.76M ﹤0.01% 4613
2022
Q1
$2.8M Buy
201,871
+31,851
+19% +$501K ﹤0.01% 5347
2021
Q4
$4.77M Buy
170,020
+43,704
+35% +$1.34M 0.01% 4367
2021
Q3
$4.29M Buy
126,316
+79,813
+172% +$2.89M ﹤0.01% 4598
2021
Q2
$1.9M Sell
46,503
-311,290
-87% -$12.1M ﹤0.01% 6744
2021
Q1
$14.4M Buy
357,793
+352,101
+6,186% +$19.1M 0.02% 2424
2020
Q4
$337K Sell
5,692
-8,161
-59% -$421K ﹤0.01% 8867
2020
Q3
$674K Sell
13,853
-36,887
-73% -$1.55M ﹤0.01% 6759
2020
Q2
$2.46M Buy
50,740
+14,763
+41% +$538K ﹤0.01% 4199
2020
Q1
$999K Sell
35,977
-21,827
-38% -$609K ﹤0.01% 5336
2019
Q4
$1.73M Sell
57,804
-60,279
-51% -$1.73M ﹤0.01% 4654
2019
Q3
$3.65M Sell
118,083
-116,288
-50% -$4.75M ﹤0.01% 3555
2019
Q2
$11.3M Buy
+234,371
New +$10.4M 0.01% 2038

Other funds holding ADPT